Numbness, tingling, burning pain in your feet or hands. These can be signs of diabetic neuropathy—nerve damage caused by diabetes.
Neuropathy affects up to 50% of people with diabetes. It can develop silently, and by the time you notice symptoms, significant nerve damage may have occurred.
The 2025 ADA guidelines emphasize early detection and comprehensive management of diabetic neuropathy. Here's what you need to know.
Chronic high blood sugar damages nerves throughout the body:
| Mechanism | Effect |
|---|
| Hyperglycemia | Direct nerve damage |
| Microvascular damage | Reduced blood flow to nerves |
| Inflammation | Nerve inflammation |
| Oxidative stress | Cellular damage |
| Advanced glycation end-products | Protein damage affecting nerves |
| Risk Factor | Why It Increases Risk |
|---|
| Duration of diabetes | Longer exposure to high glucose |
| Poor glycemic control | High A1C directly damages nerves |
| High blood pressure | Additional vascular damage |
| Dyslipidemia | Contributes to nerve damage |
| Obesity | Increases inflammation |
| Smoking | Worsens microvascular damage |
| Advanced age | Cumulative damage |
Most common type, affecting both sides of the body:
| Feature | Description |
|---|
| Location | Feet and legs first, then hands |
| Symmetry | Affects both sides |
| Pattern | "Stocking-glove" distribution |
| Prevalence | 20-30% at diagnosis, >50% after 25 years |
Affects involuntary body functions:
| System | Potential Effects |
|---|
| Cardiovascular | Resting tachycardia, exercise intolerance, orthostatic hypotension |
| Gastrointestinal | Gastroparesis, diarrhea, constipation |
| Genitourinary | Erectile dysfunction, bladder dysfunction |
| Sudomotor | Heat intolerance, dry skin, anhidrosis |
| Hypoglycemia unawareness | Loss of hypo symptoms |
Specific nerve involvement:
| Type | Description |
|---|
| Carpal tunnel | Median nerve compression |
| Ulnar neuropathy | Elbow nerve entrapment |
| Radiculoplexus neuropathy | Painful, asymmetric, often proximal |
| Cranial neuropathies | III, IV, VI nerves causing double vision |
| Symptom | Description |
|---|
| Numbness | Loss of sensation, often bilateral |
| Tingling | "Pins and needles" sensation |
| Burning pain | Worse at night |
| Sharp, stabbing pain | Like electric shocks |
| Allodynia | Pain from light touch |
| Loss of balance | Due to proprioception loss |
| Foot ulcers | From unrecognized trauma |
| System | Symptoms |
|---|
| Heart | Resting HR > 100, dizziness on standing, exercise intolerance |
| Stomach | Nausea, vomiting, early satiety, bloating |
| Bladder | Incomplete emptying, frequent UTIs |
| Sexual | Erectile dysfunction, retrograde ejaculation |
| Sweating | Excessive or decreased sweating, heat intolerance |
| Eyes | Delayed pupil adaptation to dark |
| Timing | Recommendation |
|---|
| Type 2 diabetes | Screen at diagnosis |
| Type 1 diabetes | Screen 5 years after diagnosis |
| After screening | Annually thereafter |
| Test | What It Evaluates |
|---|
| 10-g monofilament | Protective sensation (press until buckling) |
| 128-Hz tuning fork | Vibration sensation |
| Pinprick | Small fiber function |
| Ankle reflexes | Large fiber function |
| Temperature | Small fiber function |
| Nerve conduction studies | For atypical cases or confirmation |
Diagnosis of typical DSPN requires:
- Diabetes
- Typical symptoms OR
- Signs on exam OR
- Abnormal test results
| Strategy | Evidence |
|---|
| Intensive control | Prevents or delays neuropathy in type 1 |
| Type 1 diabetes | DCCT showed 60-70% risk reduction |
| Type 2 diabetes | Evidence less robust, but control still important |
| Early intervention | Greatest benefit when started early |
Key point: For type 1 diabetes, intensive control is primary prevention. For type 2, focus on multiple risk factors.
First-Line Medications
| Medication | Starting Dose | Max Dose | Evidence |
|---|
| Pregabalin | 50 mg TID | 300 mg daily | Strong evidence |
| Gabapentin | 300 mg at bedtime | 3,600 mg daily | Strong evidence |
| Duloxetine | 30 mg daily | 60 mg daily | Strong evidence |
| Venlafaxine | 37.5 mg daily | 225 mg daily | Moderate evidence |
Second-Line Options
| Medication | Considerations |
|---|
| Amitriptyline | Low cost, sedating, anticholinergic effects |
| Nortriptyline | Better tolerated than amitriptyline |
| Topical capsaicin | For localized pain |
| Lidocaine patches | For localized pain |
| Tramadol | For moderate-severe pain (short-term) |
Treatment Approach
Start first-line → Wait 4-6 weeks →
If adequate response → Continue
If inadequate → Try different first-line OR
Add second-line OR
Consider combination therapy
| Treatment | Evidence |
|---|
| Physical therapy | Improves balance, strength |
| Occupational therapy | Adaptive strategies |
| Foot care education | Prevents ulcers |
| TENS units | Some benefit for pain |
| Acupuncture | Limited evidence, may help some |
| Cognitive behavioral therapy | Helps coping with chronic pain |
| Risk | Consequence |
|---|
| Loss of sensation | Unrecognized injuries |
| Poor circulation | Delayed healing |
| Immune dysfunction | Infection risk |
| Foot deformity | Pressure points and ulcers |
| Check For | Why |
|---|
| Cuts, scratches | Can become infected |
| Blisters | May indicate shoe issues |
| Redness | Possible infection |
| Swelling | Possible injury or infection |
| Ingrown nails | Can lead to infection |
| Calluses | Can lead to ulcers |
| Feature | Why It Matters |
|---|
| Wide toe box | Prevents rubbing and pressure |
| Good support | Reduces risk of injury |
| Proper fit | Prevents friction |
| Breathable materials | Reduces moisture and infection risk |
| Custom orthotics | For foot deformities |
| Situation | Action |
|---|
| Cut not healing after 2 days | Medical evaluation |
| Redness, warmth, swelling | Possible infection—urgent |
| Fever with foot problem | Urgent care |
| New foot pain | Medical evaluation |
| Visible bone | Emergency care |
| Sign | Description |
|---|
| Resting tachycardia | HR > 100 bpm at rest |
| Orthostatic hypotension | BP drop on standing |
| Exercise intolerance | Can't increase HR normally |
| Silent ischemia | No pain with heart problems |
Significance: CAN is associated with increased mortality.
| Symptom | Description |
|---|
| Early satiety | Feeling full quickly |
| Nausea/vomiting | Especially after meals |
| Bloating | Abdominal discomfort |
| Unstable glucose | Due to unpredictable absorption |
Management:
- Small, frequent meals
- Low-fat, low-fiber foods during flares
- Prokinetic agents (metoclopramide, erythromycin)
- Glycemic optimization
| Treatment | Options |
|---|
| Oral agents | Sildenafil, tadalafil |
| Injection therapy | Alprostadil |
| Vacuum devices | Mechanical assistance |
| Referral | To urologist if first-line fails |
| Strategy | Impact |
|---|
| Glycemic control | 60-70% risk reduction in type 1 |
| Lifestyle modification | Exercise, weight loss |
| Smoking cessation | Improves microvascular health |
| Blood pressure control | Reduces vascular damage |
| Lipid management | Reduces cardiovascular risk |
| Strategy | Impact |
|---|
| Early detection | Prevents progression |
| Aggressive risk factor management | Slows progression |
| Foot care | Prevents ulcers and amputation |
| Regular screening | Early intervention |
- Neuropathy affects up to 50% of people with diabetes
- Screen annually for peripheral neuropathy
- Type 2: screen at diagnosis; Type 1: screen 5 years after diagnosis
- Multiple medications are effective for neuropathic pain
- Foot care is essential—daily inspection and proper footwear
- Glycemic control prevents neuropathy in type 1 diabetes
- Autonomic neuropathy can affect multiple organ systems
Early warning signs include numbness, tingling, or burning pain in the feet or hands, often worse at night. You may also notice balance problems or weakness. Autonomic symptoms may include dizziness on standing, digestive issues, or sexual dysfunction. However, neuropathy can be asymptomatic initially, which is why regular screening is important.
Once nerve damage has occurred, it typically cannot be reversed. However, progression can be slowed or halted with good glycemic control and risk factor management. Some symptoms, particularly pain, may improve with treatment. Early intervention offers the best chance to prevent significant damage.
First-line medications include pregabalin, gabapentin, duloxetine, and venlafaxine. The "best" medication varies by individual—what works well for one person may not work for another. Treatment often requires trial and error to find the most effective and best-tolerated option.
Foot care is critical because neuropathy reduces sensation in your feet, meaning you may not notice injuries, cuts, or sores. Combined with poor circulation (also common in diabetes), minor injuries can become serious infections that are difficult to heal and may lead to amputation. Daily foot inspections help catch problems early.
Autonomic neuropathy is diagnosed through specialized tests that measure heart rate variability, blood pressure response to standing, sweating patterns, gastric emptying studies, and bladder function. Your healthcare provider may order these tests if you have symptoms suggesting autonomic involvement.
Sources:
- American Diabetes Association. Standards of Care in Diabetes—2025. Diabetes Care 2025; 48(Suppl 1): S179-S195 (Section 14: Neuropathy)
- Pop-Busui R, et al. Diabetes Care 2024;47(Suppl 1):S158-S168 (Diabetic Neuropathy)
This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about your health, treatment, or care. Individual circumstances vary, and what is appropriate for one person may not be appropriate for another.
If you are experiencing a medical emergency, call 911 (or your local emergency number) immediately.